What is CortiCare?
CortiCare operates at the intersection of neurology and tele-health, providing clinicians with essential tools to assess real-time brain functionality. By streamlining the diagnostic process for abnormalities, the company has effectively redefined standards in neuro-critical care. Their service model, which encompasses both in-home ambulatory EEG monitoring and robust support for pharmaceutical clinical trials, addresses a critical gap in the healthcare market for timely, cost-effective neurological data. As a leader in remote diagnostic technology, CortiCare leverages proprietary workflows to ensure that high-acuity patients receive rapid, actionable insights regardless of their physical location.
How much funding has CortiCare raised?
CortiCare has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in CortiCare
PPP
Public-Private Partnership
What's next for CortiCare?
With this major strategic investment, CortiCare is well-positioned to scale its enterprise-level operations and deepen its market penetration. The company is expected to prioritize the enhancement of its diagnostic platform, potentially integrating advanced analytics to further improve clinical outcomes. By focusing on the scalability of its ambulatory EEG services, CortiCare aims to capture a larger share of the remote monitoring market, while simultaneously strengthening its role as a primary partner for organizations conducting complex neurological clinical trials. The current funding context suggests a transition toward long-term sustainability and technological dominance in the neuro-diagnostic space.
See full CortiCare company page
